Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett

Showing results (261-270 of 330) with videos related to

Pageof 33
Sort By:
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring responseSahar A Saddoughi, Elizabeth Garrett-Mayer, Uzair Chaudhary, et al.
Cancer Medicine|December 18, 2021
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologistsKathryn F Mileham, Caroline Schenkel, Suanna S Bruinooge, et al.
BMC Cancer|December 12, 2018
Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer modelsCollin Homer-Bouthiette, Yang Zhao, Lauren B Shunkwiler, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work GroupAllison Magnuson, Suanna S Bruinooge, Harpreet Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Tamoxifen-stimulated growth of breast cancer due to p21 lossAbde M Abukhdeir, Michele I Vitolo, Pedram Argani, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
Pageof 33

Showing results (261-270 of 330) with videos related to

Sort By:
Pageof 33
Cancer|November 24, 2020
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcomaNeeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring responseSahar A Saddoughi, Elizabeth Garrett-Mayer, Uzair Chaudhary, et al.
Cancer Medicine|December 18, 2021
Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologistsKathryn F Mileham, Caroline Schenkel, Suanna S Bruinooge, et al.
BMC Cancer|December 12, 2018
Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer modelsCollin Homer-Bouthiette, Yang Zhao, Lauren B Shunkwiler, et al.
Cancer Immunology, Immunotherapy : CII|February 14, 2015
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cellsMark P Rubinstein, Ee Wern Su, Samantha Suriano, et al.
Journal of Hematology & Oncology|April 9, 2017
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancerShikhar Mehrotra, Carolyn D Britten, Steve Chin, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2021
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work GroupAllison Magnuson, Suanna S Bruinooge, Harpreet Singh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Tamoxifen-stimulated growth of breast cancer due to p21 lossAbde M Abukhdeir, Michele I Vitolo, Pedram Argani, et al.
JCO Precision Oncology|June 12, 2024
Talazoparib in Patients With Solid Tumors With <i>BRCA1</i>/<i>2</i> Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalovic, Michael Rothe, Pam K Mangat, et al.
Pageof 33